Stargardt disease 1
Clinical trials for Stargardt disease 1 explained in plain language.
Never miss a new study
Get alerted when new Stargardt disease 1 trials appear
Sign up with your email to follow new studies for Stargardt disease 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy injection aims to save sight in rare eye disease
Disease control Recruiting nowThis early-phase trial tests a new gene therapy called VG801 for Stargardt disease, a genetic condition that causes vision loss. Fifteen people aged 6 and older will receive a single injection under the retina. The main goal is to check safety, but researchers will also measure a…
Matched conditions: STARGARDT DISEASE 1
Phase 1/2 • Sponsor: VeonGen Therapeutics GmbH • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Gene therapy injection aims to halt blinding eye disease
Disease control Recruiting nowThis early study tests a new gene therapy called ACDN-01 for people with Stargardt disease, a genetic condition that leads to progressive vision loss. The therapy is given as a one-time injection under the retina. The main goals are to check safety and find the right dose, with a…
Matched conditions: STARGARDT DISEASE 1
Phase 1/2 • Sponsor: Ascidian Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New study seeks volunteers for future eye disease treatment
Knowledge-focused Recruiting nowThis prescreening study aims to identify up to 50 people with ABCA4-related retinopathy, including Stargardt disease, for possible participation in future ACDN-01 clinical trials. Participants will undergo genetic testing and various eye exams to confirm their condition. This is …
Matched conditions: STARGARDT DISEASE 1
Sponsor: Ascidian Therapeutics, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC